Ce-Chem Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 1992.
1992 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Ce-Chem Pharmaceuticals Private Limited

Ce-Chem Pharmaceuticals Private Limited, a active private limited company, was established on 30 September 1992 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85310KA1992PTC013586. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.70 Cr.

Formerly known as Integrated Health And Allied Services Private Limited.. It upholds a compliant status. Employing 66 professional, Its leadership includes Chandramathi Gopalkrishna Rao (Whole-Time Director), Tejasvi Bhat (Whole-Time Director), Chandrashekar Mithoor (Managing Director). Past directors included Chandramathi Gopalkrishna Rao, Bhat Krishna Birumoole, Tejasvi Bhat. It holds ₹8.83 Cr open charges and ₹0.54 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.336, Iv Phase 9Th Cross, Peenya Industrial Area, Bangalore, Karnataka, 560058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85310KA1992PTC013586

  • Registration Number

    013586

  • Incorporation Date

    30 September 1992

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹3.70 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 3.70 Cr
  • Company Age 33 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.83 Cr
  • Satisfied Charges ₹ 0.54 M
  • Revenue Growth **** -6.25%
  • Profit Growth **** -104.23%
  • Ebitda **** -69.99%
  • Net Worth -0.37%
  • Total Assets **** 12.56%
Company report

Ce-Chem Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ce-Chem Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ce-Chem Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Chandramathi Gopalkrishna Rao Whole-Time Director 30 Sep 1992 Current
Tejasvi Bhat Whole-Time Director 08 Jan 2008 Current
Chandrashekar Mithoor Managing Director 08 Jan 2008 Current
Sarojini Mithoor Director 08 Jan 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 01 Jul 2008 Past
Pramod Abcsdd Director 08 Feb 2008 Past
Pramod Abcsdd Additional Director 30 Jun 2008 Past
Pramod Abcsdd Additional Director 30 Jun 2008 Past
Pramod Abcsdd Additional Director 30 Jun 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ce-Chem Pharmaceuticals.

Ce-Chem Pharmaceuticals Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 6.25% decrease. The company also saw a substantial fall in profitability, with a 104.23% decrease in profit. The company's net worth dipped by a decrease of 0.37%.

Ce-Chem Pharmaceuticals revenue growth over time
Ce-Chem Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -6.25%
*******
*******
*******
*******
Revenue from Operations
*******
 -6.49%
*******
*******
*******
*******
Total Assets
*******
 12.56%
*******
*******
*******
*******
Profit or Loss
*******
 -104.23%
*******
*******
*******
*******
Net Worth
*******
 -0.37%
*******
*******
*******
*******
EBITDA
*******
 -69.99%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ce-Chem Pharmaceuticals?

In 2024, Ce-Chem Pharmaceuticals had a public holding of 2.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹88,325,000.00

Satisfied Charges

₹540,000.00

Charges Breakdown by Lending Institutions
  • Sidbi : 4.54 Cr
  • State Bank Of India : 2.47 Cr
  • Karnataka State Financial Corporation : 1.62 Cr
  • Others : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
29 Nov 2024 Karnataka State Financial Corporation ₹1.62 Cr Open
31 Jul 2024 Sidbi ₹4.54 Cr Open
31 Oct 2022 Others ₹2.00 M Open
29 Nov 2008 State Bank Of India ₹2.47 Cr Open
23 May 2016 State Bank Of India ₹0.54 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ce-Chem Pharmaceuticals?

Ce-Chem Pharmaceuticals has a workforce of 66 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ce-Chem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ce-Chem Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ce-Chem Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ce-Chem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 2.47 Cr registered on 29 Nov 2008 with Charge ID 10132366 was modified on 05 Aug 2025. was documented.

  • Balance Sheet

    The activity Ce-Chem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

  • Charges

    A charge with Karnataka State Financial Corporation amounted to Rs. 1.62 Cr with Charge ID 101007964 was registered on 29 Nov 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 4.54 Cr with Charge ID 100955015 was registered on 31 Jul 2024. was documented.

  • Charges

    A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100642487 was registered on 31 Oct 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ce-Chem Pharmaceuticals Private Limited?

The CIN of Ce-Chem Pharmaceuticals Private Limited is U85310KA1992PTC013586.

Where is Ce-Chem Pharmaceuticals Private Limited headquartered?

Ce-Chem Pharmaceuticals Private Limited is headquartered at No.336, Iv Phase 9Th Cross, Peenya Industrial Area, Bangalore, Karnataka, 560058.

When was Ce-Chem Pharmaceuticals Private Limited incorporated?

Ce-Chem Pharmaceuticals Private Limited was incorporated on 30 September 1992.

Who are the current directors of Ce-Chem Pharmaceuticals Private Limited?

The current directors of Ce-Chem Pharmaceuticals Private Limited are

What is the primary industry of Ce-Chem Pharmaceuticals Private Limited?

The primary industry of Ce-Chem Pharmaceuticals Private Limited is Manufacturing.

Is Ce-Chem Pharmaceuticals Private Limited a listed company?

Ce-Chem Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ce-Chem Pharmaceuticals Private Limited?

The authorized capital of Ce-Chem Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.70 Cr.

What is the compliance status of Ce-Chem Pharmaceuticals Private Limited?

The compliance status of Ce-Chem Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available